{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:33:21Z","timestamp":1794940401118,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01273-1","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T10:56:55Z","timestamp":1764932215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Peer research with populations of people who use street tablets in areas over-represented by drug-related harms in the UK: a case study"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7256-0504","authenticated-orcid":false,"given":"Hannah Louise","family":"Poulter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0165-7552","authenticated-orcid":false,"given":"Helen J","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3674-6045","authenticated-orcid":false,"given":"Joanna","family":"Kesten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"MacKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9478-6053","authenticated-orcid":false,"given":"Gillian","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"1273_CR1","unstructured":"ONS. Deaths related to drug poisoning in England and Wales: 2021 registrations. 2022."},{"key":"1273_CR2","unstructured":"ONS. Indices of Multiple Deprivation 2019 (England),. 2019."},{"key":"1273_CR3","unstructured":"ONS. Deaths related to drug poisoning in England and Wales: 2023 registrations. 2024."},{"key":"1273_CR4","unstructured":"ONS. Deaths related to drug poisoning in England and Wales: 2020 registrations. 2021."},{"issue":"2","key":"1273_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/19491247.2021.2002660","volume":"23","author":"A Alexiou","year":"2023","unstructured":"Alexiou A, Mason K, Fahy K, Taylor-Robinson D, Barr B. Assessing the impact of funding cuts to local housing services on drug and alcohol related mortality: a longitudinal study using area-level data in England. Int J Hous Policy. 2023;23(2):362\u201380.","journal-title":"Int J Hous Policy"},{"key":"1273_CR6","doi-asserted-by":"publisher","first-page":"108518","DOI":"10.1016\/j.neuropharm.2021.108518","volume":"188","author":"H Amaro","year":"2021","unstructured":"Amaro H, Sanchez M, Bautista T, Cox R. Social vulnerabilities for substance use: stressors, socially toxic environments, and discrimination and racism. Neuropharmacology. 2021;188:108518.","journal-title":"Neuropharmacology"},{"key":"1273_CR7","unstructured":"ACMD. Commissioning impact on drug treatment. 2017 6th September 2017."},{"key":"1273_CR8","unstructured":"ONS. Middle-aged generation most likely to die by suicide and drug poisoning. 2019."},{"key":"1273_CR9","unstructured":"ONS. Domestic abuse victim characteristics, England and Wales: year ending March 2023. 2023."},{"key":"1273_CR10","unstructured":"Middlesbrough Council. Middlesborugh Joint Strategic Needs Assessment: Parental Substance Misuse. 2024."},{"key":"1273_CR11","unstructured":"Scotland\u2019s Benzo challenge. And how we can Meet it. [press release]. Scottish Drug Deaths Taskforce; 2021."},{"issue":"2","key":"1273_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.24095\/hpcdp.42.2.01","volume":"42","author":"M Boileau-Falardeau","year":"2022","unstructured":"Boileau-Falardeau M, Contreras G, Gari\u00e9py G, Laprise C. Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence. Health Promot Chronic Dis Prev Can. 2022;42(2):47\u201359.","journal-title":"Health Promot Chronic Dis Prev Can"},{"issue":"4","key":"1273_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1046\/j.1360-0443.2003.00349.x","volume":"98","author":"Conversation with Ambros Uchtenhagen","year":"2003","unstructured":"Conversation with Ambros Uchtenhagen. Addiction. 2003;98(4):389\u201396.","journal-title":"Addiction"},{"key":"1273_CR14","unstructured":"Johnson CF, Barnsdale L, McAuley A. Investigating the role of benzodiazepines in drug-related mortality: a systematic review undertaken on behalf of the Scottish National forum on Drug-Related deaths. Public Health Information for Scotland; 2016."},{"key":"1273_CR15","unstructured":"ACMD. Novel Benzodiazepines: A review of the evidence of use and harms of Novel Benzodiazepines. 2020."},{"issue":"10","key":"1273_CR16","doi-asserted-by":"publisher","first-page":"e0310655","DOI":"10.1371\/journal.pone.0310655","volume":"19","author":"B Ciesluk","year":"2024","unstructured":"Ciesluk B, Inglis DG, Parke A, Troup LJ. Systematic review: the relationship between gabapentinoids, etizolam, and drug related deaths in Scotland. PLoS ONE. 2024;19(10):e0310655.","journal-title":"PLoS ONE"},{"key":"1273_CR17","doi-asserted-by":"publisher","first-page":"116028","DOI":"10.1016\/j.psychres.2024.116028","volume":"339","author":"M Glancy","year":"2024","unstructured":"Glancy M, Palmateer N, Yeung A, Hickman M, Macleod J, Bishop J, et al. Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A National retrospective cohort study. Psychiatry Res. 2024;339:116028.","journal-title":"Psychiatry Res"},{"key":"1273_CR18","unstructured":"Ford. & Law. Guidance for the use and reduction of misuse of benzodiazepines and other hypnotics and anxiolytics in general practice2014."},{"key":"1273_CR19","doi-asserted-by":"publisher","first-page":"104025","DOI":"10.1016\/j.drugpo.2023.104025","volume":"116","author":"HL Poulter","year":"2023","unstructured":"Poulter HL, Walker T, Ahmed D, Moore HJ, Riley F, Towl G, et al. More than just \u2018free heroin\u2019: caring whilst navigating constraint in the delivery of Diamorphine assisted treatment. Int J Drug Policy. 2023;116:104025.","journal-title":"Int J Drug Policy"},{"key":"1273_CR20","unstructured":"Kesten J, Vojt G, Family H, Poulter H, Bailey C, Abdala Sheikh A, National Instute for Health Research Applied Research Collaboration West (NIHR-ARC West). 2024. Available from: https:\/\/arc-w.nihr.ac.uk\/news\/from-the-laboratory-to-the-street-doing-multidisciplinary-research-to-understand-the-rising-numbers-of-deaths-involving-opioids-and-benzodiazepines\/"},{"key":"1273_CR21","doi-asserted-by":"crossref","unstructured":"Family H, Vojt G, Poulter H, Bailey C, Cavallo D, Abdala Sheikh A et al. Benzodiazepene and opioid co-use patterns and overdose risk: a qualitative study. Int J Drug Policy 2024;In Development.","DOI":"10.1101\/2024.07.26.24311053"},{"key":"1273_CR22","unstructured":"Manchester Metropolitan University. Cutting harm from drugs: Monitoring emerging substance use trends and changes in drug markets across Greater Manchester. 2023."},{"issue":"7","key":"1273_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40264-024-01424-6","volume":"47","author":"L Tralla","year":"2024","unstructured":"Tralla L, Gustavsson S, S\u00f6derberg C, J\u00f6nsson AK, Kugelberg FC. Fatal intoxications with Zopiclone\u2014A cause for concern?? Drug Saf. 2024;47(7):687\u201397.","journal-title":"Drug Saf"},{"issue":"1","key":"1273_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-025-01153-8","volume":"22","author":"HE Family","year":"2025","unstructured":"Family HE, Vojt G, Poulter H, Bailey CP, Abdala Sheikh AP, Cavallo D, et al. A qualitative study of benzodiazepine\/z-drug and opioid co-use patterns and overdose risk. Harm Reduct J. 2025;22(1):24.","journal-title":"Harm Reduct J"},{"key":"1273_CR25","doi-asserted-by":"crossref","unstructured":"Holland A, Copeland CS, Shorter GW, Connolly DJ, Wiseman A, Mooney J, et al. Nitazenes\u2014heralding a second wave for the UK drug-related death crisis? The Lancet Public Health. 2024;9(2):e71-e2.","DOI":"10.1016\/S2468-2667(24)00001-X"},{"key":"1273_CR26","unstructured":"Stevens A. OPIOIDS IN EUROPE: PREPARING FOR A THIRD WAVE. Brookings. 2024."},{"key":"1273_CR27","doi-asserted-by":"crossref","unstructured":"Poulter H, Moore H, Crow R, Ahmed D, Walker T. Diamorphine assisted treatment in middlesbrough: A UK drug treatment case study. J Subst Use (Under Review),. 2022.","DOI":"10.1080\/14659891.2022.2120433"},{"key":"1273_CR28","unstructured":"Darko N. 2023. Available from: https:\/\/www.england.nhs.uk\/blog\/not-hard-to-reach-increasing-diversity-in-research-participation\/"},{"issue":"9","key":"1273_CR29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo Jr","year":"2021","unstructured":"Santo T Jr., Clark B, Hickman M, Grebely J, Campbell G, Sordo L, et al. Association of opioid agonist treatment with All-Cause mortality and specific causes of death among people with opioid dependence: A systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(9):979\u201393.","journal-title":"JAMA Psychiatry"},{"key":"1273_CR30","doi-asserted-by":"crossref","unstructured":"Russell C. Getting to Authentic Co-production: An Asset-Based Community Development Perspective on Co-production. 2022. p. pp 173\u2009\u2013\u200992.","DOI":"10.1007\/978-3-030-53705-0_9"},{"issue":"6","key":"1273_CR31","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1111\/hex.13836","volume":"26","author":"L Kane","year":"2023","unstructured":"Kane L, Portman RM, Eberhardt J, Walker L, Proctor E-L, Poulter H, et al. Peer supporters\u2019 mental health and emotional wellbeing needs: key factors and opportunities for co-produced training. Health Expect. 2023;26(6):2387\u201395.","journal-title":"Health Expect"},{"issue":"2","key":"1273_CR32","doi-asserted-by":"publisher","first-page":"daab098","DOI":"10.1093\/heapro\/daab098","volume":"37","author":"L den Broeder","year":"2022","unstructured":"den Broeder L, South J, Rothoff A, Bagnall A-M, Azarhoosh F, van der Linden G, et al. Community engagement in deprived neighbourhoods during the COVID-19 crisis: perspectives for more resilient and healthier communities. Health Promot Int. 2022;37(2):daab098.","journal-title":"Health Promot Int"},{"issue":"1","key":"1273_CR33","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1186\/s12889-018-5765-2","volume":"18","author":"AM Greer","year":"2018","unstructured":"Greer AM, Amlani A, Pauly B, Burmeister C, Buxton JA. Participant, peer and PEEP: considerations and strategies for involving people who have used illicit substances as assistants and advisors in research. BMC Public Health. 2018;18(1):834.","journal-title":"BMC Public Health"},{"issue":"12","key":"1273_CR34","doi-asserted-by":"publisher","first-page":"e0208410","DOI":"10.1371\/journal.pone.0208410","volume":"13","author":"R Abadie","year":"2018","unstructured":"Abadie R, Goldenberg S, Welch-Lazoritz M, Fisher CB. Establishing trust in HIV\/HCV research among people who inject drugs (PWID): insights from empirical research. PLoS ONE. 2018;13(12):e0208410.","journal-title":"PLoS ONE"},{"key":"1273_CR35","unstructured":"Office for Health Improvements and Disparities. Adult substance misuse treatment statistics 2022 to 2023: report. 2023."},{"key":"1273_CR36","unstructured":"British National Formulary (BNF): Key information on the selection, prescribing, dispensing and administration of medicines. [Internet]. 2024. Available from: https:\/\/bnf.nice.org.uk\/"},{"key":"1273_CR37","unstructured":"Housing and Communities. Rough sleeping snapshot in England: autumn 2023. 2023."},{"key":"1273_CR38","doi-asserted-by":"crossref","unstructured":"Poulter H, Moore H, Crow R, Ahmed D, Walker T. Diamorphine assisted treatment in middlesbrough: a UK drug treatment case study. J Subst Use. 2022:1\u20137.","DOI":"10.1080\/14659891.2022.2120433"},{"key":"1273_CR39","doi-asserted-by":"crossref","unstructured":"Edmundson C, Croxford S, Emanuel E, Njoroge J, Ijaz S, Hope V et al. Recent increases in crack injection and associated risk factors among people who inject psychoactive drugs in England and Wales. Int J Drug Policy. 2023:104262.","DOI":"10.1016\/j.drugpo.2023.104262"},{"key":"1273_CR40","unstructured":"Ritter A, King T, Lee N. Drug use in Australian society, 2nd ed: Oxford University Press Australia & New Zealand; 2017. xxii, 377-xxii, p."},{"issue":"1","key":"1273_CR41","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1186\/s12913-023-10201-7","volume":"23","author":"K Berry","year":"2023","unstructured":"Berry K, Matheson C, Schofield J, Dumbrell J, Parkes T, Hill D, et al. Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in scotland: an application of the MRC framework. BMC Health Serv Res. 2023;23(1):1205.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"1273_CR42","first-page":"5","volume":"13","author":"Medicines and Healthcare products Regulatory Agency (MHRA)","year":"2020","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA). Benzodiazepines and opioids: reminder of risk of potentially fatal respiratory depression. MHRA. 2020;13(8):5.","journal-title":"MHRA"},{"key":"1273_CR43","doi-asserted-by":"crossref","unstructured":"Family HE, Vojt G, Poulter H, Bailey CP, Sheikh APA, D Cavallo, et al. A qualitative study of Benzodiazepine\/Z-drug and opioid co-use patterns and overdose risk: insights for future policy and practice. MedRxiv. 2024. 2024.07.26.24311053.","DOI":"10.1101\/2024.07.26.24311053"},{"key":"1273_CR44","doi-asserted-by":"crossref","unstructured":"Matheson C, Vucic C, Dumbrell J, Robertson R, Ritchie T, Duncan C et al. Clinical outcomes of benzodiazepine prescribing for people receiving opioid agonist treatment: A systematic review of the evidence. Pharm (Basel). 2024;12(5).","DOI":"10.3390\/pharmacy12050152"},{"issue":"3","key":"1273_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10550880802122620","volume":"27","author":"B Brands","year":"2008","unstructured":"Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S. The impact of benzodiazepine use on methadone maintenance treatment outcomes. J Addict Dis. 2008;27(3):37\u201348.","journal-title":"J Addict Dis"},{"key":"1273_CR46","unstructured":"South Tees Public Health. Live Well Joint Strategic Needs Assessment (JSNA): Parental Substance Misuse. 2023."},{"key":"1273_CR47","doi-asserted-by":"crossref","unstructured":"Vojt G, Family H, Poulter H, Bailey C, Cavallo D, Abdala Sheikh A et al. Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study. MedRxiv. 2024:2024.11.29.24318190.","DOI":"10.1101\/2024.11.29.24318190"},{"issue":"2","key":"1273_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/09652149640699","volume":"91","author":"S Sikdar","year":"1996","unstructured":"Sikdar S, Ruben SM. Zopiclone abuse among polydrug users. Addiction. 1996;91(2):285\u20136.","journal-title":"Addiction"},{"key":"1273_CR49","unstructured":"European Monitoring Centre for. Drugs and Drug Addiction. Polydrug use: health and social responses. 2021."},{"key":"1273_CR50","unstructured":"Welsh Emerging WEDINOS, Drugs. & Indentification of Novel Substances Project 2025 [Available from: https:\/\/www.wedinos.org\/#:~:text=WEDINOS%20%2D%20Welsh%20Emerging%20Drugs%20%26%20Identification%20of%20Novel%20Substances%20Project"},{"key":"1273_CR51","unstructured":"Robertson R, Baylis A, Buck D, Fenney D, Ross S. Improving drug treatment services in England: Models for commissioning and accountability. 2021."},{"key":"1273_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-94-007-2138-8_10","volume-title":"Rethinking social epidemiology: towards a science of change","author":"T Rhodes","year":"2012","unstructured":"Rhodes T, Wagner K, Strathdee SA, Shannon K, Davidson P, Bourgois P. Structural violence and structural vulnerability within the risk environment: theoretical and methodological perspectives for a social epidemiology of HIV risk among injection drug users and sex workers. In: O\u2019Campo P, Dunn JR, editors. Rethinking social epidemiology: towards a science of change. Dordrecht: Springer Netherlands; 2012. pp. 205\u201330."},{"key":"1273_CR53","unstructured":"Jurgens R. Nothing about Us without Us. Greater, meaningful involvement of people who use illegal drugs: A public health, ethical, and human rights imperative. International HIV\/AIDS Alliance: Canadian HIV\/AIDS Legal Network; Open Society Institute 2008."},{"issue":"3","key":"1273_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"key":"1273_CR55","doi-asserted-by":"crossref","unstructured":"Lewer D, Croxford S, Desai M, Emanuel E, Hope VD, McAuley A et al. The characteristics of people who inject drugs in the united kingdom: changes in age, duration, and incidence of injecting, 1980\u20132019, using evidence from repeated cross-sectional surveys. Addiction. 2022;n\/a(n\/a).","DOI":"10.1111\/add.15911"},{"key":"1273_CR56","doi-asserted-by":"crossref","unstructured":"Lewer D, Hope VD, Harris M, Kelleher M, Jewell A, Pritchard M et al. Incidence and treatment costs of severe bacterial infections among people who inject heroin: A cohort study in South london, England. Drug Alcohol Depend. 2020;212.","DOI":"10.1016\/j.drugalcdep.2020.108057"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01273-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01273-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:46:29Z","timestamp":1770036389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01273-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01273-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"None disclosed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"CRediT.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"CRediT statement"}}],"article-number":"18"}}